LOS ANGELES, June 4, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humana Inc. ("Humana" or "the Company") (NYSE: HUM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period"), are encourag ...

SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Humana class action lawsuit seeks to represent purchasers or acquirers of Humana Inc. (NYSE: HUM) common stock between July 27, 2022 and January 24, 2024, inclusive (the "Class Period"). Captioned Iron Workers Local 401 Annuity Fund v. Humana Inc., No. 24-cv-00655 (D. Del.), the Humana class action lawsuit charges Humana and certain of Humana's top executives with violations of the Securities Exchange Act of 193 ...

A month has gone by since the last earnings report for Humana (HUM) . Shares have added about 13.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Humana due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Premium Growth Propels Humana to Easy Q1 Earnings Beat Human ...

Humana (HUM) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this health insurer have returned -0.7%, compared to the Zacks S&P 500 composite's -4.1% change. During this period, the Zacks Medical - HMOs industry, which Humana falls in, has lost 3.7%. The key question now is: What could be the stock's future direction?Although media re ...

Key PointsHealth insurance giant Humana reported Q1 2024 EPS of $7.23, beating consensus estimates by $1.11 as revenues rose 10.7% YoY.Humana revised its 2024 GAAP EPS guidance down to $13.93 from $14.87 and adjusted EPS down to $16.00 from the $16.13 consensus.Humana noted that the $6.00 to $10.00 adjusted EPS for 2025 will have to be cut lower but won’t know by how much until later in 2024.5 stocks we like better than HumanaHealth insurer Humana Inc. NYSE: HUM reported its Q1 2024 earnings report to a les ...

An earnings report showing growth in key categories wasn't enough to lift investor sentiment on the company.Humana (HUM -3.66%) stock has not been a favorite of investors this year, and the health insurer's first-quarter earnings report published Wednesday morning did nothing to change that. Following its release the company's stock traded down, to the point where it closed Hump Day down by almost 4% in price. Meanwhile, the bellwether S&P 500 index did relatively better, trading more or less sideways on th ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or ...

For the quarter ended March 2024, Humana (HUM) reported revenue of $29.33 billion, up 9.7% over the same period last year. EPS came in at $7.23, compared to $9.38 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $28.6 billion, representing a surprise of +2.55%. The company delivered an EPS surprise of +20.10%, with the consensus EPS estimate being $6.02.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expecta ...

Humana Inc. (HUM) delivered better-than-expected first-quarter 2024 earnings, fueled by higher premiums, improvement in the Insurance segment and growing strength in Medicare Advantage. In fact, it raised full-year individual Medicare Advantage membership guidance. However, the positives were partially offset by higher operating expenses and lower overall medical memberships.It posted adjusted earnings per share (EPS) of $7.23, beating the Zacks Consensus Estimate by 20.1%. However, the figure declined from ...

Key TakeawaysHumana shares fell in intraday trading Wednesday after it pulled its 2025 adjusted earnings guidance due to slower government healthcare spending.The health insurer explained that rates for Medicare Advantage weren't high enough to cover rising medical costs.The news offset Humana's better-than-expected first-quarter results and increased Medicare Advantage membership guidance. Humana (HUM) shares fell more than 5% in intraday trading Wednesday after it pulled its 2025 adjusted earnings guidanc ...